In particular we asked whether the mechanism in MLL-AF9 leukaemia cells was the same as that we reported in breast and colon cancers, in which transcriptional elongation is blocked at the SL-dT motif in the first intron15–18 by CDK9 inhibitors. The gene discussed is KMT2A; the disease is malignant colon neoplasm.